Altimmune Inc (NASDAQ:ALT)
| 2.44 Delayed Data As of Oct 03 |  -0.10 / -3.94%Today’s Change | 2.34 Today|||52-Week Range 17.17 | -85.17% Year-to-Date |
Latest ALT News | Press Releases
No recent news for Altimmune Inc.
Today’s Trading
| Previous close | 2.54 |
| Today’s open | 2.51 |
| Day’s range | 2.42 - 2.55 |
| Volume | 54,890 |
| Average volume (3 months) | 1,531,896 |
| Market cap | $137.0M |
Data as of 3:59pm ET, 10/03/2023
Growth & Valuation
| Earnings growth (last year) | +23.24% |
| Earnings growth (this year) | -3.73% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -101.54% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HRTXHeron Therapeutics I... | +0.04 | +3.92% |
| ADVMAdverum Biotechnolog... | -0.09 | -7.14% |
| INMBINmune Bio Inc | +0.40 | +6.06% |
| XBITXBiotech Inc | -0.04 | -1.04% |
Data as of 4:00pm ET, 10/03/2023
Financials
| Next reporting date | November 14, 2023 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | -$68.0K |
| Annual profit (last year) | -$84.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
